February 26, 2021 Experience Evernorth acquisition of MDLIVE We are advising MDLIVE on the transaction
February 24, 2021 Experience Reckitt Benckiser Group acquisition of Biofreeze We are advising RB on the acquisition
February 17, 2021 Experience Charles River Laboratories $875 million acquisition of Cognate We advised Charles River on the acquisition of a cell and gene therapy contract development and manufacturing organization
February 16, 2021 Experience Signify Health $648.6 million IPO We advised Signify Health on its IPO and NYSE listing
February 11, 2021 Experience Adagene $161 million IPO We advised Adagene on its IPO and Nasdaq listing
February 10, 2021 Experience Cornell Capital acquires trustaff and CardioSolution in combination with Stella We are advising Cornell Capital on the acquisition
February 9, 2021 Experience Bolt Biotherapeutics $230 million IPO We advised the underwriters on the IPO and Nasdaq listing
February 9, 2021 Experience Immunocore $297 million IPO We advised the joint book-running managers and underwriters on the IPO and Nasdaq listing
February 9, 2021 Experience Terns Pharmaceuticals $127.5 million IPO We advised the underwriters on the IPO and Nasdaq listing
January 8, 2021 Experience Gracell Biotechnologies $209 million IPO and Nasdaq listing We advised the underwriters on the IPO of ADSs